e-learning
resources
Berlin 2001
Monday 24.09.2001
Molecular associations with TB
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT)
U. Demkow, T. M. Zielonka, B. Bialas, M. Filewska, J. Zaleska, D. Radziukiewicz-Byszewska, E. Augustynowicz, Z. Zwolska, E. Rowinska-Zakrzewska, E. Skopinska-Rozewska (Warsaw, Poland)
Source:
Annual Congress 2001 - Molecular associations with TB
Session:
Molecular associations with TB
Session type:
Thematic Poster Session
Number:
2031
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Demkow, T. M. Zielonka, B. Bialas, M. Filewska, J. Zaleska, D. Radziukiewicz-Byszewska, E. Augustynowicz, Z. Zwolska, E. Rowinska-Zakrzewska, E. Skopinska-Rozewska (Warsaw, Poland). IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT). Eur Respir J 2001; 16: Suppl. 31, 2031
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Humoral immune response against mycobacterial antigens 38kDa and lipoarabinomannan (LAM) in extrapulmonary tuberculosis (EXTB) in adults and children
Source: Eur Respir J 2003; 22: Suppl. 45, 341s
Year: 2003
In vitro
immune response to
Mycobacterium tuberculosis
antigens
Source: Eur Respir J 2005; 26: Suppl. 49, 22s
Year: 2005
Humoral immune response against 38-kDa and 16-kDa mycobacterial antigens in tuberculosis
Source: Eur Respir J 2007; 29: 143-148
Year: 2007
Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
Deficient
in silico
selection of
mycobacterium tuberculosis
(MTB) epitopes in tuberculosis (TB) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006
Humoral response to HspX and GlcB to previous and recent infection by
mycobacterium tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
Humoral immune response to recombinant and native mycobacterial antigens in different forms of pulmonary tuberculosis (TB) in adults (A) and children (C)
Source: Eur Respir J 2004; 24: Suppl. 48, 32s
Year: 2004
Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009
IGG immune response against MPT-64, CFP-10 and ESAT-6 antigens in children with pulmonary tuberculosis
Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection
Year: 2009
Quantitative T-cell interferon-gamma responses to
Mycobacterium tuberculosis
-specific antigens in latent and active tuberculosis
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008
Tuberculosis treatment effect on T-cell interferon-γ responses to Mycobacterium tuberculosis-specific antigens
Source: Eur Respir J 2010; 36: 355
Year: 2010
Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection
Source: Eur Respir J 2010; 36: 135-142
Year: 2010
Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008
A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis
Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Year: 2009
Interferon-γ release assays using RD1 antigens in nontuberculous mycobacterial infections. A systematic review
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007
Early BCG vaccination is unrelated to pulmonary immunity against Mycobacterium tuberculosis in adults
Source: Eur Respir J 2014; 44: 1087-1090
Year: 2014
Nontuberculous mycobacterial infections
Source: Eur Respir Mon 2011; 52: 115-129
Year: 2011
Evaluation of a IFN-γ test using
Mycobacterium tuberculosis
-specific antigens for diagnosis of active tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 142s
Year: 2006
Impact of T-SPOT.
TB
test to exclude active
Mycobacterium tuberculosis
complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Glycopeptidolipids for evaluating the role of non-tuberculous mycobacteria in latent tuberculosis infection diagnosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept